Literature DB >> 26418692

Best Reconstructive Techniques: Improving the Final Scar.

Brundha Balaraman1, Elizabeth R Geddes, Paul M Friedman.   

Abstract

BACKGROUND: Abnormal cutaneous scarring is due to excessive growth of fibrous tissue in response to traumatic or iatrogenic tissue injury and may adversely affect a patient's quality of life. The success of a surgical procedure is often tied to the cosmetic outcome.
OBJECTIVES: To provide a synthesis of available literature and provide guidelines for the management of cutaneous scars with laser technology.
MATERIALS AND METHODS: An extensive review of the medical literature was conducted to assess optimal treatment methods for cutaneous scars based on scar features, location, and skin phototype. Recommendations and algorithms were described based on this review and our current clinical experience.
RESULTS: Combination therapy with laser and non-laser modalities offers a safe and effective method for scar revision.
CONCLUSION: Armed with an understanding of relevant available therapies, skillful dermatologic surgeons may drastically improve the final scar cosmesis. This review discusses current and emerging laser therapy approaches to scar revision.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26418692     DOI: 10.1097/DSS.0000000000000496

Source DB:  PubMed          Journal:  Dermatol Surg        ISSN: 1076-0512            Impact factor:   3.398


  6 in total

1.  Angiotensin-converting enzyme inhibitor works as a scar formation inhibitor by down-regulating Smad and TGF-β-activated kinase 1 (TAK1) pathways in mice.

Authors:  Wei-Qiang Tan; Qing-Qing Fang; Xiao Z Shen; Jorge F Giani; Tuantuan V Zhao; Peng Shi; Li-Yun Zhang; Zakir Khan; You Li; Liang Li; Ji-Hua Xu; Ellen A Bernstein; Kenneth E Bernstein
Journal:  Br J Pharmacol       Date:  2018-10-08       Impact factor: 8.739

2.  Treatment of atrophic acne scarring with fractional micro-plasma radio-frequency in Chinese patients: A prospective study.

Authors:  Ting Lan; Yan Xiao; Li Tang; Michael R Hamblin; Rui Yin
Journal:  Lasers Surg Med       Date:  2018-04-16       Impact factor: 4.025

3.  Nanofat Injection for the Treatment of Depressed Facial Scars.

Authors:  Rong Huang; Hu Jiao; Jincai Fan; Liqiang Liu; Jia Tian; Cheng Gan; Zengjie Yang; Tiran Zhang; Yan Zeng; Zhiguo Su
Journal:  Aesthetic Plast Surg       Date:  2021-02-26       Impact factor: 2.326

4.  Angiotensin-converting enzyme inhibitor reduces scar formation by inhibiting both canonical and noncanonical TGF-β1 pathways.

Authors:  Qing-Qing Fang; Xiao-Feng Wang; Wan-Yi Zhao; Shi-Li Ding; Bang-Hui Shi; Ying Xia; Hu Yang; Li-Hong Wu; Cai-Yun Li; Wei-Qiang Tan
Journal:  Sci Rep       Date:  2018-02-20       Impact factor: 4.379

5.  The Important Factors Associated with Treatment Response in Laser Treatment of Facial Scars: A Single-Institution Based Retrospective Study.

Authors:  Youngkyoung Lim; Ji-Hye Park; Dong-Youn Lee; Na-Young Hwang; Soohyun Ahn; Jong Hee Lee
Journal:  Ann Dermatol       Date:  2019-01-02       Impact factor: 1.444

6.  Use of Condensed Nanofat Combined With Fat Grafts to Treat Atrophic Scars.

Authors:  Zichun Gu; Yirun Li; Hua Li
Journal:  JAMA Facial Plast Surg       Date:  2018-03-01       Impact factor: 4.611

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.